1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,035 | 0,040 | 06.02. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Lifecare ASA: Lifecare submits updated documentation to NoMA: regulatory review resumes in first-in-human study application | - | Oslo Børs | ||
| 30.01. | Lifecare ASA: PFU rules that Finansavisen breached press ethics in coverage of Lifecare s market disclosures | 2 | Oslo Børs | ||
| 30.01. | Lifecare ASA: Information about the warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 29.01. | Lifecare ASA: Mandatory notification of trade - allocation of Underwriting Commission Shares and Warrants | - | Oslo Børs | ||
| 29.01. | Lifecare ASA: Resolution to issue underwriting commission shares | - | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 28.01. | Lifecare ASA: Share capital increase and warrants registered | - | Oslo Børs | ||
| 23.01. | Lifecare ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
| 23.01. | Lifecare ASA: Financial calendar | - | Oslo Børs | ||
| 22.01. | Lifecare ASA: Major shareholding notification | 2 | Oslo Børs | ||
| 22.01. | Lifecare ASA: Final results of the Rights Issue | - | Oslo Børs | ||
| 22.01. | Lifecare ASA: Mandatory notification of trade subscription of shares in rights issue | 1 | Oslo Børs | ||
| 21.01. | Lifecare ASA: Last day of the subscription period for the Rights Issue | 2 | Oslo Børs | ||
| 19.01. | Lifecare ASA: Lifecare highlights real-world veterinary relevance from ongoing diabetes study | 3 | Oslo Børs | ||
| 15.01. | Lifecare ASA: Last day of trading in Subscription Rights | 3 | Oslo Børs | ||
| 14.01. | Lifecare ASA: Mandatory notification of trade subscription of shares in rights issue | 2 | Oslo Børs | ||
| 13.01. | Lifecare ASA: Lifecare s implant continues to track glucose where traditional CGMs reach their limits | 4 | Oslo Børs | ||
| 12.01. | Lifecare ASA: Invitation to webcast presentation on 13 January 2026 at 11:30 CET | 2 | Oslo Børs | ||
| 08.01. | Lifecare ASA: Major shareholding notification | 4 | Oslo Børs | ||
| 08.01. | Lifecare ASA: Lifecare confirms reproducible implant tracks glucose in vivo | 6 | Oslo Børs | ||
| 07.01. | Lifecare ASA: Mandatory notification of trade allocation of subscription rights | 7 | Oslo Børs |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 73,07 | +0,63 % | This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday | ||
| SERNOVA BIOTHERAPEUTICS | 0,086 | -7,53 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 63,80 | -1,24 % | ROUNDUP: Boston Scientific Guides Q1, FY26 In Line With Estimates | WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) initiated its adjusted earnings and sales... ► Artikel lesen | |
| PAUL HARTMANN | 222,00 | -0,89 % | Vorläufiges Jahresergebnis 2025: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - Die HARTMANN GRUPPE hat im Geschäftsjahr 2025 ein vorläufiges organisches Umsatzwachstum von 2,2 % erzielt.Das vorläufige bereinigte EBITDA liegt mit 277 Mio. EUR um rund 15 Mio.... ► Artikel lesen | |
| SYSMEX | 8,150 | 0,00 % | Fujirebio und Sysmex beginnen Vertriebskooperation für Demenz-Tests | Fujirebio Holdings, Inc. (Zentrale: Minato-ku, Tokio; President CEO: Goki Ishikawa; "Fujirebio"), eine konsolidierte Tochtergesellschaft der H.U. Group Holdings, Inc. (Zentrale: Minato-ku, Tokio;... ► Artikel lesen | |
| ADDLIFE | 14,370 | -0,83 % | AddLife AB: Year-end report January 1 - December 31, 2025 | Continued positive margin development, strong profit and cash flow"The EBITA margin continues to develop positively and profits are growing. The strong cash flow means that our ambition to reduce the... ► Artikel lesen | |
| EMBECTA | 9,150 | -0,54 % | Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results | PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| ENOVIS | 19,000 | -0,52 % | Enovis Corporation: Enovis Appoints Oliver Engert as Chief Administrative Officer | Dallas, TX, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative... ► Artikel lesen | |
| PULMONX | 1,310 | +2,34 % | Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates | WASHINGTON (dpa-AFX) - Several healthcare and biotech stocks posted notable gains in after-hours trading on Monday, driven by earnings updates, executive appointments, and capital market activity.Pulmonx... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle CEO Walker, CFO Murray resign | ||
| SI-BONE | 12,900 | -0,77 % | SI-BONE To Report Q4 And FY2025 Results This Month; What Does Preliminary Results Indicate? | ||
| KOOTH | 1,520 | 0,00 % | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | ||
| PEIJIA MEDICAL | 0,685 | 0,00 % | PEIJIA-B (09996): VOLUNTARY ANNOUNCEMENT - UNAUDITED OPERATING STATISTICS FOR THE YEAR ENDED DECEMBER 31, 2025 | ||
| BACTIGUARD | 1,395 | +12,05 % | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2025 | A year of strategic execution concluded with a strong Q4
Fourth quarter 2025 (October - December)
Total revenue amounted to SEK 65.6 (68.3) million, a decrease of SEK 2.7 million corresponding to... ► Artikel lesen | |
| SCIBASE | 0,026 | -0,75 % | SciBase: Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue | STOCKHOLM, Feb. 6, 2026 /PRNewswire/ -- In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April... ► Artikel lesen |
Das Unternehmen LIFECARE ASA kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -43,01 % bei einem Aktienkurs von 0,022 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.